Dr. Jonathan Himmelfarb is Professor of Medicine and Director of the Center for Kidney Disease Innovation at the Icahn School of Medicine at Mount Sinai. Previously he was Co-Director and Co-Founder of the University of Washington Center for Dialysis Innovation, Director of the Kidney Research Institute, Professor of Medicine and Adjunct Professor of Bioengineering.
He is a leading national and international expert on uremia, dialysis, chronic kidney disease, and acute kidney injury. Dr. Himmelfarb has held leadership positions in many national and international nephrology societies, including President of the American Society of Nephrology. He has served on expert panels for the U.S. Food and Drug Administration, Veterans Health Administration, Centers for Medicare & Medicaid Services and other organizations. He has served on editorial boards including JASN, CJASN Kidney International, BMC Medicine, Nature reviews Nephrology, the Faculty of 1000 in Medicine and Research. He is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), and the American Society of Nephrology, and has held leadership roles in multiple NIH funded consortia, including the NIDDK Kidney Precision Medicine Project and the NCATS Tissue Chips Consortium.
Dr Himmelfarb has led numerous investigator-initiated clinical trials and cohort studies, as well as multicenter collaborative studies. He is the author of more than 400 peer-reviewed publications, with over 50,000 citations.
